Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from IDT Australia Limited ( (AU:IDT) ).
IDT Australia Limited announced a change in the director’s interest in securities, with Geoffrey Sam acquiring additional ordinary fully paid shares through on-market trades. This acquisition increases his total holdings, potentially signaling confidence in the company’s future performance and stability, which may positively impact stakeholder perception.
More about IDT Australia Limited
IDT Australia Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of high-quality pharmaceutical products. The company is known for its expertise in drug formulation and production, serving both domestic and international markets.
YTD Price Performance: -9.09%
Average Trading Volume: 329,529
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$41.35M
Find detailed analytics on IDT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue